#BEGIN_DRUGCARD DB02923

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
1133-63-7

# ChEBI_ID:
16205

# Chemical_Formula:
C12H10O2

# Chemical_IUPAC_Name:
3-phenylbenzene-1,2-diol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Biphenyl-2,3-Diol

# HET_ID:
BPY

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C12H10O2/c13-11-8-4-7-10(12(11)14)9-5-2-1-3-6-9/h1-8,13-14H

# InChI_Key:
InChIKey=YKOQAAJBYBTSBS-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C02526

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2923

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
186.2066

# Molecular_Weight_Mono:
186.068079564

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1KWC

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.46

# Predicted_LogS:
-2.5

# Predicted_Water_Solubility:
5.52e-01 g/l

# Primary_Accession_No:
DB02923

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
254

# PubChem_Substance_ID:
46507022

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00746

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC1=C(O)C(=CC=C1)C1=CC=CC=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:39 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X66122

# Drug_Target_1_GenBank_ID_Protein:
397884

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
bphC

# Drug_Target_1_Gene_Sequence:
>897 bp
ATGAGCATCAGAAGTTTGGGATACATGGGGTTTGCGGTCAGCGACGTAGCTGCTTGGCGT
TCGTTTCTGACGCAGAAACTGGGCTTGATGGAAGCGGGCACGACCGACAACGGCGACCTG
TTCCGCATCGATTCGAGAGCCTGGCGGATCGCCGTTCAGCAGGGCGAGGTTGACGATCTG
GCCTTTGCCGGCTACGAGGTGGCCGATGCGGCAGGGCTGGCGCAGATGGCTGACAAGCTC
AAACAGGCCGGTATCGCAGTCACCACCGGCGATGCCTCATTGGCCAGGCGCCGCGGGGTG
ACCGGATTGATCACCTTTGCCGACCCGTTTGGCCTGCCGTTGGAAATTTACTATGGCGCC
AGCGAGGTGTTCGAAAAACCGTTCCTGCCTGGTGCGGCCGTGTCGGGTTTCCTGACCGGC
GAGCAAGGGCTGGGGCATTTCGTGCGCTGCGTTCCGGATTCGGACAAGGCGCTGGCGTTT
TATACCGACGTGCTCGGCTTCCAGTTGTCTGACGTCATCGACATGAAAATGGGGCCGGAC
GTGACGGTTCCTGCGTACTTCCTGCACTGCAACGAACGCCACCACACCCTGGCAATTGCG
GCATTCCCGCTGCCAAAACGCATTCATCACTTCATGCTCGAAGTCGCCTCGCTCGATGAC
GTCGGCTTTGCATTTGATCGGGTTGACGCGGACGGCTTGATCACCTCCACGCTGGGGCGC
CACACCAATGACCACATGGTGTCGTTCTATGCCTCGACCCCGTCCGGAGTAGAGGTCGAG
TATGGCTGGAGTGCCCGTACCGTTGACCGCTCCTGGGTTGTGGTGAGGCACGACAGTCCG
AGCATGTGGGGCCACAAGTCTGTGCGCGACAAAGCAGCTGCGCGCAACAAAGCATGA

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
7481800	Han S, Eltis LD, Timmis KN, Muchmore SW, Bolin JT: Crystal structure of the biphenyl-cleaving extradiol dioxygenase from a PCB-degrading pseudomonad. Science. 1995 Nov 10;270(5238):976-80.
8344527	Hofer B, Eltis LD, Dowling DN, Timmis KN: Genetic analysis of a Pseudomonas locus encoding a pathway for biphenyl/polychlorinated biphenyl degradation. Gene. 1993 Aug 16;130(1):47-55.
9857017	Vaillancourt FH, Han S, Fortin PD, Bolin JT, Eltis LD: Molecular basis for the stabilization and inhibition of 2, 3-dihydroxybiphenyl 1,2-dioxygenase by t-butanol. J Biol Chem. 1998 Dec 25;273(52):34887-95.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2392

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
32471

# Drug_Target_1_Name:
Biphenyl-2,3-diol 1,2-dioxygenase

# Drug_Target_1_Number_of_Residues:
298

# Drug_Target_1_PDB_ID:
1LKD

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00903	Glyoxalase

# Drug_Target_1_Protein_Sequence:
>Biphenyl-2,3-diol 1,2-dioxygenase
MSIRSLGYMGFAVSDVAAWRSFLTQKLGLMEAGTTDNGDLFRIDSRAWRIAVQQGEVDDL
AFAGYEVADAAGLAQMADKLKQAGIAVTTGDASLARRRGVTGLITFADPFGLPLEIYYGA
SEVFEKPFLPGAAVSGFLTGEQGLGHFVRCVPDSDKALAFYTDVLGFQLSDVIDMKMGPD
VTVPAYFLHCNERHHTLAIAAFPLPKRIHHFMLEVASLDDVGFAFDRVDADGLITSTLGR
HTNDHMVSFYASTPSGVEVEYGWSARTVDRSWVVVRHDSPSMWGHKSVRDKAAARNKA

# Drug_Target_1_Reaction:
biphenyl-2,3-diol + O2 = 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate + H2O

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Shows a preference for catechols with groups immediately adjacent to the hydroxyl substituents

# Drug_Target_1_SwissProt_ID:
P47228

# Drug_Target_1_SwissProt_Name:
BPHC_BURXL

# Drug_Target_1_Synonyms:
2,3-dihydroxybiphenyl dioxygenase
23OHBP oxygenase
DHBD
EC 1.13.11.39

# Drug_Target_1_Theoretical_pI:
5.99

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
M26433

# Drug_Target_2_GenBank_ID_Protein:
151099

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
bphC

# Drug_Target_2_Gene_Sequence:
>882 bp
ATGAGTATCGAACGTTTGGGCTACCTCGGCTTCGCCGTCAAGGATGTACCCGCCTGGGAC
CACTTTCTGACCAAGAGCGTGGGTTTGATGGCTGCGGGTTCGGCTGGCGACGCTGCGCTG
TACCGGGCCGATCAGCGTGCCTGGCGCATCGCCGTGCAGCCGGGCGAACTCGACGACCTG
GCCTACGCAGGCTTGGAAGTGGATGACGCCGCCGCGCTCGAGCGCATGGCCGACAAGCTG
CGCCAGGCAGGGGTGGCCTTCACCCGCGGTGACGAAGCGCTCATGCAGCAGCGCAAGGTC
ATGGGCCTGCTGTGTCTGCAAGATCCGTTCGGCCTGCCGCTCGAGATTTACTACGGCCCG
GCAGAAATCTTTCATGAGCCCTTCCTGCCTAGCGCCCCCGTGTCGGGCTTCGTCACGGGC
GACCAGGGCATCGGGCACTTCGTGCGCTGCGTGCCCGACACGGCGAAGGCGATGGCTTTC
TACACCGAGGTGCTTGGCTTTGTGCTGTCGGACATCATTGACATCCAGATGGGGCCGGAA
ACGAGCGTGCCCGCGCACTTTCTGCACTGCAATGGCCGTCACCACACGATCGCCCTGGCT
GCTTTCCCGATCCCGAAGCGCATCCACCACTTCATGCTGCAAGCCAACACCATCGACGAT
GTGGGCTACGCCTTCGATCGGCTGGACGCCGCCGGGCGCATCACCTCCCTGCTCGGGCGC
CACACCAACGACCAGACGCTCTCCTTCTATGCCGACACGCCGTCGCCCATGATCGAGGTC
GAGTTCGGCTGGGGGCCGCGCACAGTGGATTCCTCCTGGACGGTGGCGCGACACAGCCGC
ACGGCCATGTGGGGTCACAAGTCGGTACGCGGCCAGCGCTGA

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
11293547	Uragami Y, Senda T, Sugimoto K, Sato N, Nagarajan V, Masai E, Fukuda M, Mitsu Y: Crystal structures of substrate free and complex forms of reactivated BphC, an extradiol type ring-cleavage dioxygenase. J Inorg Biochem. 2001 Feb;83(4):269-79.
12206778	Sato N, Uragami Y, Nishizaki T, Takahashi Y, Sazaki G, Sugimoto K, Nonaka T, Masai E, Fukuda M, Senda T: Crystal structures of the reaction intermediate and its homologue of an extradiol-cleaving catecholic dioxygenase. J Mol Biol. 2002 Aug 23;321(4):621-36.
2540155	Kimbara K, Hashimoto T, Fukuda M, Koana T, Takagi M, Oishi M, Yano K: Cloning and sequencing of two tandem genes involved in degradation of 2,3-dihydroxybiphenyl to benzoic acid in the polychlorinated biphenyl-degrading soil bacterium Pseudomonas sp. strain KKS102. J Bacteriol. 1989 May;171(5):2740-7.
8048958	Fukuda M, Yasukochi Y, Kikuchi Y, Nagata Y, Kimbara K, Horiuchi H, Takagi M, Yano K: Identification of the bphA and bphB genes of Pseudomonas sp. strains KKS102 involved in degradation of biphenyl and polychlorinated biphenyls. Biochem Biophys Res Commun. 1994 Jul 29;202(2):850-6.
8636975	Senda T, Sugiyama K, Narita H, Yamamoto T, Kimbara K, Fukuda M, Sato M, Yano K, Mitsui Y: Three-dimensional structures of free form and two substrate complexes of an extradiol ring-cleavage type dioxygenase, the BphC enzyme from Pseudomonas sp. strain KKS102. J Mol Biol. 1996 Feb 9;255(5):735-52.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3032

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
32245

# Drug_Target_2_Name:
Biphenyl-2,3-diol 1,2-dioxygenase

# Drug_Target_2_Number_of_Residues:
293

# Drug_Target_2_PDB_ID:
1KW9

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00903	Glyoxalase

# Drug_Target_2_Protein_Sequence:
>Biphenyl-2,3-diol 1,2-dioxygenase
MSIERLGYLGFAVKDVPAWDHFLTKSVGLMAAGSAGDAALYRADQRAWRIAVQPGELDDL
AYAGLEVDDAAALERMADKLRQAGVAFTRGDEALMQQRKVMGLLCLQDPFGLPLEIYYGP
AEIFHEPFLPSAPVSGFVTGDQGIGHFVRCVPDTAKAMAFYTEVLGFVLSDIIDIQMGPE
TSVPAHFLHCNGRHHTIALAAFPIPKRIHHFMLQANTIDDVGYAFDRLDAAGRITSLLGR
HTNDQTLSFYADTPSPMIEVEFGWGPRTVDSSWTVARHSRTAMWGHKSVRGQR

# Drug_Target_2_Reaction:
biphenyl-2,3-diol + O2 = 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate + H2O

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Biphenyl-2,3-diol + O(2) = 2-hydroxy-6-oxo-6- phenylhexa-2,4-dienoate + H(2)O

# Drug_Target_2_SwissProt_ID:
P17297

# Drug_Target_2_SwissProt_Name:
BPHC_PSES1

# Drug_Target_2_Synonyms:
2,3-dihydroxybiphenyl dioxygenase
23OHBP oxygenase
DHBD
EC 1.13.11.39

# Drug_Target_2_Theoretical_pI:
6.23

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_3_Essentiality:
Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
M60405

# Drug_Target_3_GenBank_ID_Protein:
294350

# Drug_Target_3_GeneCard_ID:
doxG

# Drug_Target_3_Gene_Name:
doxG

# Drug_Target_3_Gene_Sequence:
>315 bp
ATGACAGTAAAGTGGATTGAAGCAGTCGCTCTTTCTGACATCCTTGAAGGTGACGTCCTC
GGCGTGACTGTCGAGGGCAAGGAGCTGGCGCTGTATGAAGTTGAAGGCGAAATCTACGCT
ACCGACAACCTGTGCACGCATGGTTCCGCCCGCATGAGTGATGGTTATCTCGAGGGTAGA
GAAATCGAATGCCCCTTGCATCAAGGTCGGTTTGACGTTTGCACAGGCAAAGCCCTGTGC
GCACCCGTGACACAGAACATCAAAACATATCCAGTCAAGATTGAGAACCTGCGCGTAATG
ATTGATTTGAGCTAA

# Drug_Target_3_General_Function:
Involved in ferrous iron binding

# Drug_Target_3_General_References:
8226631	Denome SA, Stanley DC, Olson ES, Young KD: Metabolism of dibenzothiophene and naphthalene in Pseudomonas strains: complete DNA sequence of an upper naphthalene catabolic pathway. J Bacteriol. 1993 Nov;175(21):6890-901.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
6457

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
33941.4

# Drug_Target_3_Name:
1,2-dihydroxynaphthalene dioxygenase

# Drug_Target_3_Number_of_Residues:
302

# Drug_Target_3_PDB_ID:
Not Available

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00903	Glyoxalase

# Drug_Target_3_Protein_Sequence:
>1,2-dihydroxynaphthalene dioxygenase
MSKQAAVIELGYMGISVKDPDAWKSFATDMLGLQVLDEGEKDRFYLRMDYWHHRIVVHHN
GQDDLEYLGWRVAGKPEFEALGQKLIDAGYKIRICDKVEAQERMVLGLMKTEDPGGNPTE
IFWGPRIDMSNPFHPGRPLHGKFVTGDQGLGHCIVRQTDVAEAHKFYSLLGFRGDVEYRI
PLPNGMTAELSFMHCNARDHSIAFGAMPAAKRLNHLMLEYTHMEDLGYTHQQFVKNEIDI
ALQLGIHANDKALTFYGATPSGWLIEPGWRGATAIDEAEYYVGDIFGHGVEATGYGLDVK
LS

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Catalyzes the meta-cleavage of the substrate's aromatic ring

# Drug_Target_3_SwissProt_ID:
P0A108

# Drug_Target_3_SwissProt_Name:
NAHC_PSEU8

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
5.83

# Drug_Target_3_Transmembrane_Regions:
None

#END_DRUGCARD DB02923
